Hippocratic AI has grown its team by 107% over the past year and is accelerating hiring. Its latest executive appointments span clinical, commercial, operational, customer success, and people leadership functions further deepening the company’s healthcare expertise.

Hippocratic AI, global leader and pioneer of generative AI healthcare agents, announced today that it has more than doubled the size of its team in the past year, and is expanding its executive leadership team with the addition of industry veterans across key functions. These strategic hires position the company to meet rising demand across providers, payors, government, and life sciences sectors, while advancing its mission to deliver healthcare abundance through scalable, patient-facing generative AI. The growth also strengthens the company’s ability to support its expanding partner network with the operational depth, clinical insight, and responsiveness needed to ensure successful deployment and long-term value. Hippocratic AI earlier this month raised its Series C funding and has surpassed 115 million patient interactions.

“We’re experiencing extraordinary momentum as health systems, payors, and life sciences organizations embrace safe generative AI agents to close critical care gaps and provide healthcare abundance,” said Munjal Shah, CEO and Co-founder of Hippocratic AI. “We welcome this world-class group of executives who bring deep expertise in healthcare, go-to-market strategy, and operations. Their leadership helps us scale responsibly while setting the standard for safe, effective generative AI in healthcare.”

New Executive Appointments:

• Anan Kashyap, Chief Financial Officer
  
  A seasoned finance leader, Anan has held key roles at Xero, Ethos, Poshmark, GrubHub, and Kayak, successfully guiding multiple companies through IPOs, acquisitions, and global expansion. He brings a deep understanding of operational scale, strategic investment, and financial discipline.
• Craig Ikens, Chief Commercial Officer, Blues and Regional Plans
  
  Craig brings 25+ years of experience in healthcare strategy and business development, including a decade at HCSC and leadership roles at Livongo and Teladoc Health. He now joins Hippocratic AI’s payor-facing initiatives.
• Dr. Herprit Mahal MD, FACP, Associate Chief Medical Officer
  
  Herprit is a practicing hospital physician at Kaiser Permanente and formerly a medical director at Suki. She brings over two decades of clinical experience and a passion for using technology to expand access to high-quality, evidence-based care. Her leadership spans perioperative medicine, medical education, and AI innovation in healthcare.
• Peter Casasanto, Chief Commercial Officer, Pharma
  
  Peter brings 20+ years of commercial leadership at the intersection of AI and life sciences, most recently serving as Commercial Head of Tempus AI’s AI Apps Business Unit following its acquisition of Deep 6 AI. He previously held C-level roles at SOPHiA Genetics and Deep 6 AI.
• Rahul Agarwal, MBBS, MBA, MHSA, Chief Customer Officer
  
  A physician and enterprise healthcare leader, Rahul brings 20+ years of experience in clinical operations, customer success, and AI implementation. He previously led Sales and Client Success at TeleTracking Technologies and held senior roles at Qventus and Catholic Health Initiatives (now CommonSpirit Health).
• Sejal Rajagopalan, Chief People Officer
  
  With over two decades of experience building HR functions at growth-stage companies including SmithRx, C3, and ServiceMax, Sejal has a strong track record of scaling people operations and guiding organizations through expansion periods, while maintaining a strong culture.
• Dr. Shubhra Jain, MD, MBA, Chief Business Officer
  
  Dr. Jain is a physician, product leader, and healthcare investor with prior roles at Tarsadia Investments, Cota Capital, and a prior healthcare AI startup. At Hippocratic AI, she leads commercial strategy and partnerships across the healthcare ecosystem.

This expanded company growth and leadership team ensures the company remains equipped to deliver enterprise-grade solutions rooted in clinical safety, patient trust, and measurable patient impact.

About Hippocratic AI

Hippocratic AI has developed the safest generative AI Agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251120209392/en/